Search
for
Did you mean BRAF Mutation?
Sort by
Research 30 of 361
- Lentiginous melanoma. A clinically malignant entity that histopathologically seems benign. Case study harbouring BRAF V 600R mutation
- Hair and nail adverse events during treatment with targeted therapies for metastatic melanoma
- Hair(y) Matters in Melanoma Biology
- Diagnosis and Management of Melanoma of the Scalp: A Review of the Literature
- Is knowledge about the genetic and epigenetic alterations in melanoma a basis for targeted therapy?
- A cross-sectional study of clinical, dermoscopic, histopathological, and molecular patterns of scalp melanoma in patients with or without androgenetic alopecia
- A cross-sectional study of clinical, dermoscopic, histopathological, and molecular patterns of scalp melanoma in patients with or without androgenetic alopecia
- Inflammatory and non-melanocytic tumoral pathology of the nail
- Dyad of infantile cutaneous and thymic Langerhans cell histiocytosis: Is it rare?
- Author response: Dynamics of nevus development implicate cell cooperation in the growth arrest of transformed melanocytes
- At the Root: Cutaneous Langerhans Cell Histiocytosis
- Decision letter: Dynamics of nevus development implicate cell cooperation in the growth arrest of transformed melanocytes
- Genetics of thyroid lesions updated
- Melanocytes: The new Black
- Exploiting the origins of Ras mediated squamous cell carcinoma to develop novel therapeutic interventions
- Targeted therapy in melanoma
- Melanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating Cells
- LB1031 Immune Cell-Mediated Amplification of Stem Cell Activation in Hairy Melanocytic Nevus via Osteopontin-CD44 Axis
- Targeting the Warburg Effect in Anaplastic Thyroid Carcinoma: Metabolic Vulnerabilities and Therapeutic Opportunities
- Natural Compounds Targeting MAPK, PI3K/Akt, and JAK/STAT Signaling in Papillary Thyroid Cancer
- America - A Diversity of Life Styles.
- Kinase Inhibition with BAY 43–9006 in Renal Cell Carcinoma
- Biological therapy in the treatment of melanoma
- Can you diagnose hair loss (Non-scarring alopecia)
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- B‐ RAF , naevi and melanoma: a complex relationship
- Nevus Sebaceus With Novel HRAS Sequence Variant Mutation Misdiagnosed as Alopecia Areata
- BRAF Inhibitor Dabrafenib in Patients with Metastatic <i>BRAF</i>-Mutant Thyroid Cancer
- Abstract 1677: Epithelial hyperplasia induced by a selective B-Raf inhibitor, WYE-130600
- B-Raf and C-Raf Are Required for Melanocyte Stem Cell Self-Maintenance